BR112023018665A2 - Métodos e sistemas para desenvolvimento de protocolos de mistura - Google Patents

Métodos e sistemas para desenvolvimento de protocolos de mistura

Info

Publication number
BR112023018665A2
BR112023018665A2 BR112023018665A BR112023018665A BR112023018665A2 BR 112023018665 A2 BR112023018665 A2 BR 112023018665A2 BR 112023018665 A BR112023018665 A BR 112023018665A BR 112023018665 A BR112023018665 A BR 112023018665A BR 112023018665 A2 BR112023018665 A2 BR 112023018665A2
Authority
BR
Brazil
Prior art keywords
identifying
developing
systems
methods
predictive models
Prior art date
Application number
BR112023018665A
Other languages
English (en)
Inventor
Jordan Byrd
Matthew Oremland
Ross Kenyon
Original Assignee
Regeneron Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Regeneron Pharma filed Critical Regeneron Pharma
Publication of BR112023018665A2 publication Critical patent/BR112023018665A2/pt

Links

Classifications

    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16C—COMPUTATIONAL CHEMISTRY; CHEMOINFORMATICS; COMPUTATIONAL MATERIALS SCIENCE
    • G16C20/00—Chemoinformatics, i.e. ICT specially adapted for the handling of physicochemical or structural data of chemical particles, elements, compounds or mixtures
    • G16C20/10—Analysis or design of chemical reactions, syntheses or processes
    • G—PHYSICS
    • G06—COMPUTING; CALCULATING OR COUNTING
    • G06F—ELECTRIC DIGITAL DATA PROCESSING
    • G06F30/00—Computer-aided design [CAD]
    • G06F30/20—Design optimisation, verification or simulation
    • G06F30/28—Design optimisation, verification or simulation using fluid dynamics, e.g. using Navier-Stokes equations or computational fluid dynamics [CFD]
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01F—MIXING, e.g. DISSOLVING, EMULSIFYING OR DISPERSING
    • B01F27/00—Mixers with rotary stirring devices in fixed receptacles; Kneaders
    • B01F27/80—Mixers with rotary stirring devices in fixed receptacles; Kneaders with stirrers rotating about a substantially vertical axis
    • B01F27/808—Mixers with rotary stirring devices in fixed receptacles; Kneaders with stirrers rotating about a substantially vertical axis with stirrers driven from the bottom of the receptacle
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01F—MIXING, e.g. DISSOLVING, EMULSIFYING OR DISPERSING
    • B01F27/00—Mixers with rotary stirring devices in fixed receptacles; Kneaders
    • B01F27/80—Mixers with rotary stirring devices in fixed receptacles; Kneaders with stirrers rotating about a substantially vertical axis
    • B01F27/85—Mixers with rotary stirring devices in fixed receptacles; Kneaders with stirrers rotating about a substantially vertical axis with two or more stirrers on separate shafts
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01F—MIXING, e.g. DISSOLVING, EMULSIFYING OR DISPERSING
    • B01F27/00—Mixers with rotary stirring devices in fixed receptacles; Kneaders
    • B01F27/80—Mixers with rotary stirring devices in fixed receptacles; Kneaders with stirrers rotating about a substantially vertical axis
    • B01F27/91—Mixers with rotary stirring devices in fixed receptacles; Kneaders with stirrers rotating about a substantially vertical axis with propellers
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01F—MIXING, e.g. DISSOLVING, EMULSIFYING OR DISPERSING
    • B01F35/00—Accessories for mixers; Auxiliary operations or auxiliary devices; Parts or details of general application
    • B01F35/20—Measuring; Control or regulation
    • B01F35/22—Control or regulation
    • B01F35/2201—Control or regulation characterised by the type of control technique used
    • B01F35/2207—Use of data, i.e. barcodes, 3D codes or similar type of tagging information, as instruction or identification codes for controlling the computer programs, e.g. for manipulation, handling, production or compounding in mixing plants
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16C—COMPUTATIONAL CHEMISTRY; CHEMOINFORMATICS; COMPUTATIONAL MATERIALS SCIENCE
    • G16C20/00—Chemoinformatics, i.e. ICT specially adapted for the handling of physicochemical or structural data of chemical particles, elements, compounds or mixtures
    • G16C20/80—Data visualisation
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16C—COMPUTATIONAL CHEMISTRY; CHEMOINFORMATICS; COMPUTATIONAL MATERIALS SCIENCE
    • G16C60/00—Computational materials science, i.e. ICT specially adapted for investigating the physical or chemical properties of materials or phenomena associated with their design, synthesis, processing, characterisation or utilisation
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01F—MIXING, e.g. DISSOLVING, EMULSIFYING OR DISPERSING
    • B01F2101/00—Mixing characterised by the nature of the mixed materials or by the application field
    • B01F2101/22—Mixing of ingredients for pharmaceutical or medical compositions
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01F—MIXING, e.g. DISSOLVING, EMULSIFYING OR DISPERSING
    • B01F2215/00—Auxiliary or complementary information in relation with mixing
    • B01F2215/04—Technical information in relation with mixing
    • B01F2215/0404—Technical information in relation with mixing theories or general explanations of phenomena associated with mixing or generalizations of a concept by comparison of equivalent methods
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01F—MIXING, e.g. DISSOLVING, EMULSIFYING OR DISPERSING
    • B01F2215/00—Auxiliary or complementary information in relation with mixing
    • B01F2215/04—Technical information in relation with mixing
    • B01F2215/0409—Relationships between different variables defining features or parameters of the apparatus or process
    • G—PHYSICS
    • G05—CONTROLLING; REGULATING
    • G05B—CONTROL OR REGULATING SYSTEMS IN GENERAL; FUNCTIONAL ELEMENTS OF SUCH SYSTEMS; MONITORING OR TESTING ARRANGEMENTS FOR SUCH SYSTEMS OR ELEMENTS
    • G05B13/00—Adaptive control systems, i.e. systems automatically adjusting themselves to have a performance which is optimum according to some preassigned criterion
    • G05B13/02—Adaptive control systems, i.e. systems automatically adjusting themselves to have a performance which is optimum according to some preassigned criterion electric
    • G05B13/04—Adaptive control systems, i.e. systems automatically adjusting themselves to have a performance which is optimum according to some preassigned criterion electric involving the use of models or simulators
    • G05B13/048—Adaptive control systems, i.e. systems automatically adjusting themselves to have a performance which is optimum according to some preassigned criterion electric involving the use of models or simulators using a predictor
    • G—PHYSICS
    • G05—CONTROLLING; REGULATING
    • G05B—CONTROL OR REGULATING SYSTEMS IN GENERAL; FUNCTIONAL ELEMENTS OF SUCH SYSTEMS; MONITORING OR TESTING ARRANGEMENTS FOR SUCH SYSTEMS OR ELEMENTS
    • G05B17/00—Systems involving the use of models or simulators of said systems

Abstract

métodos e sistemas para desenvolvimento de protocolos de mistura. um método para desenvolver um modelo preditivo pode incluir a identificação de parâmetros de protocolo de mistura para o modelo preditivo, a identificação de um critério de avaliação para o modelo preditivo, a seleção de valores de teste para os parâmetros do protocolo de mistura, a identificação de uma simulação de dinâmica computacional de fluidos (cfd) necessária para ser realizada em a fim de gerar os critérios de avaliação, conduzindo a simulação de cfd para cada combinação de valores de teste, gerando assim critérios de avaliação correspondentes a cada combinação de valores de teste, gerando um domínio de modelos preditivos potenciais relacionando os parâmetros do protocolo de mistura ao critério de avaliação, identificando um conjunto de modelos preditivos candidatos do domínio de modelos preditivos potenciais e classificando o conjunto de modelos preditivos candidatos.
BR112023018665A 2021-03-26 2022-03-25 Métodos e sistemas para desenvolvimento de protocolos de mistura BR112023018665A2 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202163166504P 2021-03-26 2021-03-26
US202263298880P 2022-01-12 2022-01-12
PCT/US2022/071363 WO2022204728A1 (en) 2021-03-26 2022-03-25 Methods and systems for developing mixing protocols

Publications (1)

Publication Number Publication Date
BR112023018665A2 true BR112023018665A2 (pt) 2023-10-03

Family

ID=81308160

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112023018665A BR112023018665A2 (pt) 2021-03-26 2022-03-25 Métodos e sistemas para desenvolvimento de protocolos de mistura

Country Status (9)

Country Link
US (1) US20220309215A1 (pt)
EP (1) EP4315344A1 (pt)
KR (1) KR20230162932A (pt)
AU (1) AU2022243005A1 (pt)
BR (1) BR112023018665A2 (pt)
CA (1) CA3211302A1 (pt)
IL (1) IL305731A (pt)
TW (1) TW202244475A (pt)
WO (1) WO2022204728A1 (pt)

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7087411B2 (en) 1999-06-08 2006-08-08 Regeneron Pharmaceuticals, Inc. Fusion protein capable of binding VEGF
KR100562195B1 (ko) 2002-03-08 2006-03-20 에이에스엠엘 네델란즈 비.브이. 리소그래피용 마스크, 마스크 제조방법, 리소그래피장치및 디바이스제조방법
RS52643B (en) 2006-06-02 2013-06-28 Regeneron Pharmaceuticals Inc. HIGH AFINITY ANTIBODIES TO THE HUMAN IL-6 RECEPTOR
US7608693B2 (en) 2006-10-02 2009-10-27 Regeneron Pharmaceuticals, Inc. High affinity human antibodies to human IL-4 receptor
DK2178916T3 (en) 2007-07-31 2015-01-12 Regeneron Pharma Human antibodies to human cd20 and method thereof for use
JO3672B1 (ar) 2008-12-15 2020-08-27 Regeneron Pharma أجسام مضادة بشرية عالية التفاعل الكيماوي بالنسبة لإنزيم سبتيليسين كنفرتيز بروبروتين / كيكسين نوع 9 (pcsk9).
JO3417B1 (ar) 2010-01-08 2019-10-20 Regeneron Pharma الصيغ المستقرة التي تحتوي على الأجسام المضادة لمضاد مستقبل( interleukin-6 (il-6r
JO3340B1 (ar) 2010-05-26 2019-03-13 Regeneron Pharma مضادات حيوية لـعامل تمايز النمو 8 البشري
AR083044A1 (es) 2010-09-27 2013-01-30 Regeneron Pharma Anticuerpos anti-cd48 y usos de los mismos
KR101867279B1 (ko) 2010-10-06 2018-06-15 리제너론 파아마슈티컬스, 인크. 항―인터류킨―４ 수용체（ｉｌ－４ｒ） 항체를 함유하는 안정화된 제형
JO3756B1 (ar) 2010-11-23 2021-01-31 Regeneron Pharma اجسام مضادة بشرية لمستقبلات الجلوكاجون
AR087329A1 (es) 2011-06-17 2014-03-19 Regeneron Pharma Anticuerpos humanos contra proteina 3 de tipo angiopoietina humana
WO2013074557A1 (en) 2011-11-14 2013-05-23 Regeneron Pharmaceuticals, Inc. Compositions and methods for increasing muscle mass and muscle strength by specifically antagonizing gdf8 and/or activin a
MX357393B (es) 2012-01-23 2018-07-06 Regeneron Pharma Formulaciones estabilizadas que contienen anticuerpos anti - ang2.
JO3820B1 (ar) 2012-05-03 2021-01-31 Regeneron Pharma أجسام مضادة بشرية لـ fel d1وطرق لاستخدامها
TWI641619B (zh) 2012-06-25 2018-11-21 美商再生元醫藥公司 抗－ｅｇｆｒ抗體及其用途
NZ704771A (en) 2012-08-13 2018-02-23 Regeneron Pharma Anti-pcsk9 antibodies with ph-dependent binding characteristics
JOP20200236A1 (ar) 2012-09-21 2017-06-16 Regeneron Pharma الأجسام المضادة لمضاد cd3 وجزيئات ربط الأنتيجين ثنائية التحديد التي تربط cd3 وcd20 واستخداماتها
JO3405B1 (ar) 2013-01-09 2019-10-20 Regeneron Pharma الأجسام المضادة لمضاد مستقبل عامل النمو المشتق من الصفائح الدموية - بيتا واستخداماتها
JO3532B1 (ar) 2013-03-13 2020-07-05 Regeneron Pharma الأجسام المضادة لمضاد انترلوكين-33 واستعمالاتها
TWI659968B (zh) 2013-03-14 2019-05-21 再生元醫藥公司 針對呼吸道融合病毒ｆ蛋白質的人類抗體及其使用方法
WO2014152195A1 (en) 2013-03-15 2014-09-25 Regeneron Pharmaceuticals, Inc. Il-33 antagonists and uses thereof
TWI641620B (zh) 2013-08-21 2018-11-21 再生元醫藥公司 抗－ｐｒｌｒ抗體及其用途
TWI681969B (zh) 2014-01-23 2020-01-11 美商再生元醫藥公司 針對ｐｄ-１的人類抗體
TWI680138B (zh) 2014-01-23 2019-12-21 美商再生元醫藥公司 抗ｐｄ-ｌ１之人類抗體
HUE045307T2 (hu) 2014-03-11 2019-12-30 Regeneron Pharma EGFRVIII-ellenes antitestek és alkalmazásaik
TWI754319B (zh) 2014-03-19 2022-02-01 美商再生元醫藥公司 用於腫瘤治療之方法及抗體組成物
US9795121B2 (en) 2014-05-05 2017-10-24 Regeneron Pharmaceuticals, Inc. Humanized C3 animals
MX2017003535A (es) 2014-09-16 2017-10-27 Regeneron Pharma Anticuerpos anti-glucagon y sus usos.

Also Published As

Publication number Publication date
IL305731A (en) 2023-11-01
EP4315344A1 (en) 2024-02-07
CA3211302A1 (en) 2022-09-29
KR20230162932A (ko) 2023-11-29
US20220309215A1 (en) 2022-09-29
WO2022204728A1 (en) 2022-09-29
AU2022243005A1 (en) 2023-10-05
TW202244475A (zh) 2022-11-16

Similar Documents

Publication Publication Date Title
Scheike et al. Predicting cumulative incidence probability by direct binomial regression
Preinerstorfer et al. Parameter recovery and model selection in mixed Rasch models
Hasselbring Benchmarking as empirical standard in software engineering research
US10296844B2 (en) Automatic discovery of message ordering invariants in heterogeneous logs
Wang et al. Towards modeling the style of translators in neural machine translation
BR112023018665A2 (pt) Métodos e sistemas para desenvolvimento de protocolos de mistura
Schneider et al. Towards debugging sentiment lexicons
Kumar et al. Reliability analysis of software with three types of errors and imperfect debugging using Markov model
Kabir Compositional dependability analysis of dynamic systems with uncertainty
AR125604A1 (es) Métodos y sistemas para el desarrollo de protocolos de mezcla
Wickramage Quality assurance for data science: Making data science more scientific through engaging scientific method
Diwaker et al. Assessment of ant colony using component based software engineering metrics
Sroka et al. Genetic algorithms in test design automation
Saveta et al. LANCE: A Generic Benchmark Generator for Linked Data.
Aslam et al. Refining active learning to increase behavioral coverage
Saxena et al. Realiability Assessment Model to Estimate Quality of the Effective E-Procurement Process in Adoption
Rochman et al. Predicting the final result of student national test with extreme learning machine
Smith et al. Tools for analysis of accelerated life and degradation test data
Clark et al. Conservation of mass analysis for Bio-PEPA
McMillan Process-based diagnostics for hydrologic models
Tumer et al. Design of complex engineered systems
YAMADA Performability analysis considering debugging behaviors for open source solution
Wang et al. An iterative self‐refining and self‐evaluating approach for protein model quality estimation
Arroyo Riquelme et al. A new method for applying choosing by advantages (CBA) multicriteria decision to a large number of design alternatives
Chadha et al. Interaction among foreign direct investment, economic growth and foreign trade: evidence from India and China